pasireotide long-acting depot (CAM4071)
/ Camurus
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 29, 2024
Pharmacokinetics and pharmacodynamics of a pasireotide subcutaneous depot (CAM4071) and comparison with immediate and long-acting release pasireotide.
(PubMed, Endocrine)
- "CAM4071 provided long-acting release of pasireotide over at least one month, with high bioavailability and onset and duration of IGF-1 suppression similar to pasireotide LAR."
Journal • PK/PD data • IGF1
1 to 1
Of
1
Go to page
1